CD4 and thyroid gland carcinoma: Because tetrac, in various non-thyroidal cancer cells studied to-date, is anti-proliferative, pro-apoptotic, and anti-angiogenic [8,37]—the antithesis of T4 [19,21,22,23,24,38]—several implications of tetrac studies are clear.